2022
DOI: 10.7554/elife.73420
|View full text |Cite
|
Sign up to set email alerts
|

DunedinPACE, a DNA methylation biomarker of the pace of aging

Abstract: Background: Measures to quantify changes in the pace of biological aging in response to intervention are needed to evaluate geroprotective interventions for humans. Previously we showed that quantification of the pace of biological aging from a DNA-methylation blood test was possible (Belsky et al. 2020). Here we report a next-generation DNA-methylation biomarker of Pace of Aging, DunedinPACE (for Pace of Aging Calculated from the Epigenome).Methods: We used data from the Dunedin Study 1972-3 birth cohort trac… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

21
517
1
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 352 publications
(540 citation statements)
references
References 77 publications
21
517
1
1
Order By: Relevance
“…Another recently reported second generation approach, called DunedinPACE, uses longitudinal phenotypic training data to produce a measure of the rate of biological aging. 16,17 DNAm clocks have excellent predictive ability and are responsive to known anti-aging/lifespan extending interventions such as caloric restriction. 11 Although mechanistic questions on the nature of DNAm clocks remain, these clocks represent the current gold standard aging biomarker and are now widely utilized in the aging field, including in human clinical trials.…”
Section: Main Textmentioning
confidence: 99%
“…Another recently reported second generation approach, called DunedinPACE, uses longitudinal phenotypic training data to produce a measure of the rate of biological aging. 16,17 DNAm clocks have excellent predictive ability and are responsive to known anti-aging/lifespan extending interventions such as caloric restriction. 11 Although mechanistic questions on the nature of DNAm clocks remain, these clocks represent the current gold standard aging biomarker and are now widely utilized in the aging field, including in human clinical trials.…”
Section: Main Textmentioning
confidence: 99%
“…Biological aging is the gradual, progressive decline in system integrity that causes morbidity and disability ( Field et al, 2018 ; Belsky et al, 2022 ). Field et al (2018) and Belsky et al (2020 , 2022) quantitated the pace of biological aging from a DNAm blood test. The vascular stiffness of the elderly population increases with aging.…”
Section: Discussionmentioning
confidence: 99%
“…Epigenetics, specifically DNA methylation (DNAm), is linked to aging ( Day et al, 2013 ; Horvath, 2013 ; Tharakan et al, 2020 ). DNAm is the most abundant epigenetic marker in the human genome for controlling gene expression ( Belsky et al, 2022 ). It usually occurs in CpG islands and is mostly in the proximal promoter region of the human genome, which modifies an individual’s biological function by regulating gene expression or genome sequence stability ( Deng et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…These are collectively known as epigenetic clocks, and a large body of literature demonstrates these clocks predict lifespan [27, 28], are associated with age-related conditions [28-30], and are reflective of one’s biological age [27, 31]. Second, prediction of aging-related morbidity, disability, and mortality by DNAm biomarkers is enhanced by the incorporation of physiological data into prediction algorithms [27, 28, 32]. This suggests utility in including physical fitness in DNAm biomarkers, however, current DNAm biomarkers do not use fitness parameters in their construction.…”
Section: Introductionmentioning
confidence: 99%
“…Second, prediction of aging-related morbidity, disability, and mortality by DNAm biomarkers is enhanced by the incorporation of physiological data into prediction algorithms [27,28,32]. This suggests utility in including physical fitness in DNAm biomarkers, however, current DNAm biomarkers do not use fitness parameters in their construction.…”
Section: Introductionmentioning
confidence: 99%